通过收集医生意见和通过Sermo的全球社交平台提供有针对性的内容，Movember为前列腺癌患者提供额外支持

纽约，纽约，2021年9月28日/ B3C newswire / - True North，金宝搏官网mga global prostate cancer website created by Movember , the leading charity focused on men's health, has partnered with Sermo to provide physicians with enhanced resources for their prostate cancer patients. The partnership offers doctors and other HCPs on the Sermo platform access to True North’s educational content and tools pertaining to men’s health and prostate cancer.

Sermo will collect data and insights from their ... 2021年9月28日星期二16:00:00+0200 //www.whuphiv.com/202109282270/movember-and-sermo-partner-to-increase-physician-conversation-around-prostate-cancer.html //www.whuphiv.com/202109282269/delta-4-announces-dr-hans-lehrach-to-join-scientific-advisory-board.html

VIENNA, Austria, September 28, 2021 / B3C newswire / -- Delta 4 , a digital drug discovery company focusing on the identification of new indications for existing drug compounds, today announced that Dr. Hans Lehrach will join its Scientific Advisory Board. Prof. Lehrach is a distinguished scientist in the area of genomics.

„We are excited to have Dr. Lehrach join our Scientific Advisory Board“, commented Kurt Herpel, CEO, Delta 4. Herpel added: „His insights and his direction as an eminent expert in genetics and personalized medicine will be a boost for Delta 4 as we are accelerating the application of our ... Tue, 28 Sep 2021 12:00:00 +0200 //www.whuphiv.com/202109282269/delta-4-announces-dr-hans-lehrach-to-join-scientific-advisory-board.html //www.whuphiv.com/202109282268/probiogen-s-directedluck-transposase-licensed-by-top15-global-biopharma-company.html

BERLIN, Germany, September 28, 2021 / B3C newswire / -- ProBioGen today announced the closing of a DirectedLuck Transposase Technology research license agreement with another global biopharma company. The license covers the evaluation of the DirectedLuck Transposase technology in their cell line development processes.

DirectedLuck builds on a transposase's principle but with additional major improvements. It has been optimized to recognize specific chromatin marks, guiding the transgene to genomic regions with highest transcriptional activity, which ensures exceptionally high protein expression and maximum stability. The clone pools generated within days to weeks are highly representative of later clones. ... Tue, 28 Sep 2021 09:45:00 +0200 //www.whuphiv.com/202109282268/probiogen-s-directedluck-transposase-licensed-by-top15-global-biopharma-company.html //www.whuphiv.com/202109222267/bd-completes-study-investigating-performance-of-glass-prefillable-syringes-pfs-in-deep-cold-storage.html 研究表明，玻璃PFS可在-20℃和-40℃条件下保存，且不影响PFS关键产品的功能，为进一步评估深冷条件下PFS联合用药的稳定性和性能提供了途径。 

FRANKLIN LAKES, N.J., September 22, 2021 / B3C newswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, completed a preliminary study investigating the impact of deep cold storage (-20°C and -40°C) on glass PFS.

While traditional vaccine formulations are commonly stored up to about 2°C-8°C, new vaccine formulations – including those for mRNA – require much colder storage for ... 星期三，9月22日09:00:00 +0200 //www.whuphiv.com/202109222267/bd-completes-study-investigating-performance-of-glass-prefillable-syringes-pfs-in-deep-cold-storage.html //www.whuphiv.com/202109212266/vetter-s-contribution-to-climate-protection-corporate-sites-around-the-world-are-co2-neutral.html < p > < / p > < p > < >强劲的长期可持续性战略制药服务提供者回报< em > < / em > < /强> < / p > < ul > <李data-mce-word-list = " 1 " > < >强连续投资节能和环保技术< /强> < /李> <李data-mce-word-list = " 1 " > < >强劲购买绿色能源和提供可持续机动性

RAVENSBURG, Germany, September 21, 2021 / B3C newswire /—— The " Vetter added this topic to its corporate agenda many years ago. Now, the pharmaceutical service provider is making ... Tue, 21 Sep 2021 15:30:00 +0200 //www.whuphiv.com/202109212266/vetter-s-contribution-to-climate-protection-corporate-sites-around-the-world-are-co2-neutral.html //www.whuphiv.com/202109212265/pureos-bioventures-expands-the-team-by-the-appointment-of-venture-188体育手机版partners.html

PFÄFFIKON, Switzerland, September 21, 2021 / B3C newswire / -- Pureos Bioventures , a venture capital fund dedicated to support private biotech companies developing novel therapies, announced the appointment of several venture partners to its team. The first-time fund has USD 205 million under management and has invested in 11 private biotech companies so far. In addition, Pureos is a partner at BaseLaunch, an incubator of biotech startups in Basel, Switzerland. First portfolio companies of Pureos Bioventures have already gone public or have been acquired.

As new venture partners Dr. Dragan Grabulovski, Ian Metcalfe and Dr. Roberto Iacone have joined the ... Tue, 21 Sep 2021 07:00:00 +0200 //www.whuphiv.com/202109212265/pureos-bioventures-expands-the-team-by-the-appointment-of-venture-188体育手机版partners.html //www.whuphiv.com/202109202264/cellbox-solutions-establishes-subsidiary-in-the-usa.html

HAMBURG, Germany, September 20, 2021 / B3C newswire / -- Cellbox Solutions GmbH , developer of the patented Cellbox technology, has founded their U.S. company and is now selling products directly to the U.S./North American market.

Following the successful development and production of the Cellbox transportable CO₂ incubator in 2019, as well as suitable UN3373 packaging materials for cell transport, the young company has decided to expand into the USA. The high amount of enquiries from the US market made it obvious to take the next step and expand to the USA. The market was previously served by a distribution partner, but effective ... 星期一，9月20日14:00:00 +0200 //www.whuphiv.com/202109202264/cellbox-solutions-establishes-subsidiary-in-the-usa.html //www.whuphiv.com/202109142263/almost-75-of-doctors-say-they-have-seen-an-increase-in-covid-19-in-children-but-only-10-or-less-of-children-12-are-breakthrough-cases-new-survey-shows.html Sermo的COVID-19实时晴雨表调查显示，5-12岁儿童的风险最高，疲劳是COVID-19的主要长期症状。< /强> < / p > < p > < >强纽约,纽约,9月14日2021 / B3C新闻专线/ < / >强近百分金宝搏官网mg之七十五的医生看过COVID情况下儿童的增加,主要是由于三角洲变体,45%的医生看到最大的5 - 12岁的孩子中,增加一个新的全球调查的1528名医生发现。

In Sermo’s most recent COVID-19 Real Time Barometer survey , most physicians reported that they have not seen long-COVID or long-haul cases among children, however, a substantial 26% did say they have ... 周二，9月14日15:00:00 +0200 //www.whuphiv.com/202109142263/almost-75-of-doctors-say-they-have-seen-an-increase-in-covid-19-in-children-but-only-10-or-less-of-children-12-are-breakthrough-cases-new-survey-shows.html //www.whuphiv.com/202109082262/retrobrain-announces-strategic-cooperation-with-schenker-technologies-and-a-grant-for-its-second-product-line-memorehome.html

• 申克科技，以其高端笔记本电脑和两个自有品牌XMG和SCHENKER的台式电脑而闻名，以及其作为扩展现实技术的全欧洲运营专业分销商的服务，将成为“memore”产品系列所有治疗性游戏机的独家硬件供应商和实现经理，在这一合作关系的基础上，Retrobain将能够应对由于领先的法定医疗机构最近做出的定期报销（“Regelversorgung”）的积极决定而导致的不断增长的需求。。。188体育手机版 周三，9月8日 //www.whuphiv.com/202109082262/retrobrain-announces-strategic-cooperation-with-schenker-technologies-and-a-grant-for-its-second-product-line-memorehome.html //www.whuphiv.com/202108242261/biogenes-and-fyonibio-combine-their-scientific-expertise-and-cooperate-on-pharmacokinetic-and-immunogenicity-analyses.html > < < tr > < td风格=“宽度:50%;“>,< / td > < td风格= " text-align:right;"> 
  • This collaboration covers a broad range of services, from antibody development to the analysis of clinical samples
  • The individual expertise of each company makes them ideal partners
  • The first customer projects are expected to start in the next couple of weeks

  BERLIN, Germany, August 24, 2021 / B3C newswire / --  Pharmacokinetic and immuno­genicity projects can be both diverse and complex, involving work packages from antibody generation and production to the analysis of clinical samples with validated assays. At the end of June, an agreement was signed by BioGenes GmbH and ... 8月24日星期二14:00:00 +0200 //www.whuphiv.com/202108242261/biogenes-and-fyonibio-combine-their-scientific-expertise-and-cooperate-on-pharmacokinetic-and-immunogenicity-analyses.html //www.whuphiv.com/202108162260/new-capacity-helps-eliminate-bottleneck-for-covid-19-vaccines.html

  Opening a new facility, Biotage triples its production capacity for equipment crucial in the supply chain for the production of mRNA vaccines.

  UPPSALA, Sweden, August 16, 2021 / B3C newswire / -- Biotage is one of the few companies offering a complete solution and ready to go off-the-shelf products for the purification of large-scale lipids, used in mRNA vaccine development and production. Expanding its production capacity of large-scale flash columns by 300 per cent, Biotage is now helping pharmaceutical companies and contract manufacturers’ scale up lipid production for COVID-19 vaccines. A new, bespoke production facility is now operational at ... 8月16日星期一14:00:00 +0200 //www.whuphiv.com/202108162260/new-capacity-helps-eliminate-bottleneck-for-covid-19-vaccines.html //www.whuphiv.com/202108122259/aok-baden-wuerttemberg-initiates-innovative-training-for-the-elderly-with-therapeutic-gaming-solution-memore-in-care-facilities.html > < < tr > < td风格=“宽度:50%;“>,< / td > < td风格= " text-align:吧,”>,< / td > < / tr > < / tbody > < /表> < p > < >强预防老年护理通过计算机,治疗培训项目:< /强> < / p > < ul > <李data-mce-word-list = " 1 " > <强>玩memoreCare导致加强心理表现,立场和步态安全以及肌肉运动的技巧,耐力和协调性。

  2021 / B3C newswire / -- The digital health company RetroBrain R&D reaches another important milestone in the field of prevention and health promotion according to §5 SGB XI (German Social Security Act) with the preventive training ... 8月12日星期四14:30:00 +0200 //www.whuphiv.com/202108122259/aok-baden-wuerttemberg-initiates-innovative-training-for-the-elderly-with-therapeutic-gaming-solution-memore-in-care-facilities.html //www.whuphiv.com/202108122258/nobelpharma-signs-a-license-agreement-for-probiogen-s-vaccine-manufacturing-platform-age1-cr-pix.html

  2021 / B3C newswire / -- ProBioGen is pleased to announce that Nobelpharma has signed a license agreement for the use of the AGE1.CR.pIX vaccine production platform to develop their lead vaccine. The signing of the agreement is yet another milestone in a series of fruitful collaborations between Nobelpharma and ProBioGen, among them the successful development of a highly efficient manufacturing process for Nobelpharma's highly relevant viral vaccine.

  The advantages of ProBioGen's proven cell-based production platform for industrial processes are evident: Designed as true suspension cell line, the AGE1.CR.pIX grows in chemically ... 8月12日星期四14:00:00 +0200 //www.whuphiv.com/202108122258/nobelpharma-signs-a-license-agreement-for-probiogen-s-vaccine-manufacturing-platform-age1-cr-pix.html //www.whuphiv.com/202108102257/veraxa-biotech-and-indivumed-cooperate-on-the-development-of-precision-oncology-antibody-drugs.html

  > < < tr > < td风格=“宽度:50%;“>,< / td > < td风格= " text-align:right;"> 

  HEIDELBERG and HAMBURG, Germany, August 10, 2021 / B3C newswire / -- VERAXA Biotech GmbH , Heidelberg, and Indivumed GmbH , Hamburg, announced today their agreement to jointly discover modulatory and functional antibodies against several targets that are relevant for colorectal cancer. The targets have been identified by Indivumed’s discovery solution platform nRavel®, only two months after its launch. The antibody development and commercialization will be performed by Indivumed’s subsidiary, Ix Therapeutics.

  VERAXA Biotech GmbH is a pioneer in microfluidic technology for the screening of antibodies with modulatory function on complex signal proteins like GPCRs ... 8月10日星期二14:00:00 +0200 //www.whuphiv.com/202108102257/veraxa-biotech-and-indivumed-cooperate-on-the-development-of-precision-oncology-antibody-drugs.html //www.whuphiv.com/202108062256/bd-and-certest-biotec-announce-ce-mark-for-molecular-test-to-detect-identify-certain-sars-cov-2-variants.html > < < tr > < td风格=“宽度:50%;“>,< / td > < td风格= " text-align:> 

  VIASURE SARS-CoV-2 Variant Real Time PCR Detection Kit for BD MAX™System2021 / B3C newswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec, today announced the CE mark for a molecular test that can detect and distinguish between the Alpha (B.1.1.7), Beta (B.1.351) and Gamma (P.1) SARS-CoV-2 variants.

  VIASURE SARS-CoV-2 Variant Real Time PCR Detection Kit for BD MAX™ can be used as a combined test ... 8月6日星期五09:00:00 +0200 //www.whuphiv.com/202108062256/bd-and-certest-biotec-announce-ce-mark-for-molecular-test-to-detect-identify-certain-sars-cov-2-variants.html